Young women are dying of high blood pressure at four times the rate they were in 1999

American College of Cardiology (ACC.26)

Between 1999 and 2023, the rate at which American women aged 25 to 44 died from hypertensive heart disease rose from 1.1 to 4.8 per 100,000. That is a more than fourfold increase in a population most clinicians do not flag as high-risk for cardiovascular events.

The findings, presented at the American College of Cardiology's Annual Scientific Session (ACC.26), draw on 25 years of U.S. death certificate data and add up to a toll that is hard to look away from: more than 29,000 young women dead from a condition that is, in most cases, preventable.

A demographic most doctors overlook

Nearly half of all Americans have high blood pressure. It is called the "silent killer" for a reason: it damages heart muscle and blood vessels for years without producing obvious symptoms. But the cardiovascular research community has historically directed its attention toward men and postmenopausal women. Younger women rarely see cardiologists, and studies examining hypertensive heart disease risk in this age group have been scarce.

"Rising mortality for young women with hypertensive heart disease reflects an underestimation of cardiovascular risk, delayed diagnosis and missed opportunities for early intervention," said Alexandra Millhuff, DO, a resident physician at the University of New Mexico and the study's lead author.

The problem is not just that hypertension goes undetected. Studies have consistently shown that women are prescribed blood pressure-lowering medications at lower rates than men. Heart disease awareness campaigns have traditionally centered on older populations. The result is a gap between who is at risk and who is being treated.

Race, region, and a gap that refuses to close

The study revealed disparities that compound the already troubling trend. Non-Hispanic Black women had the highest hypertension-related mortality rate over the study period at 8.6 per 100,000 — nearly four times the rate of non-Hispanic White women at 2.3 per 100,000.

Geography mattered, too. Women in the South had the highest rate at 3.8 per 100,000, compared to 2.8 in the Midwest, 2.2 in the Northeast, and 1.9 in the West. Interestingly, the researchers found no significant difference between urban and rural populations — the divide ran along regional and racial lines, not density.

These patterns mirror broader health disparities in the United States, where access to preventive care, insurance coverage, and chronic disease management vary sharply by race and geography. But applying those broad explanations to a specific outcome — young women dying of a manageable condition — sharpens the urgency.

Pregnancy, perimenopause, and windows of vulnerability

Women face cardiovascular risks that men do not. Hormonal shifts during pregnancy can trigger gestational hypertension and preeclampsia, conditions that elevate long-term heart disease risk even after delivery. Perimenopause brings its own hemodynamic changes. The researchers emphasized that controlling blood pressure before these transitions — not after symptoms appear — is critical.

The updated ACC/AHA guidelines for blood pressure management now recommend treatment to maintain readings below 130/80 mm Hg. That threshold is lower than previous standards, reflecting growing evidence that even modestly elevated blood pressure compounds damage over time. For a 30-year-old woman with untreated hypertension, the cumulative effect over a decade can mean weakened heart muscle, coronary artery disease, heart failure, or stroke.

Lifestyle modifications — quitting smoking, exercise, dietary changes — remain the first-line approach, with antihypertensive medications added when those measures fall short. But the prerequisite to any of this is diagnosis, and diagnosis requires screening.

The primary care bottleneck

Most women between 25 and 44 do not see cardiologists. Their cardiovascular health, if it is monitored at all, falls to primary care physicians and OB-GYNs. The researchers argued that these providers need to screen more aggressively for hypertension in younger women and address risk factors early.

"Even though hypertension is more prevalent in older populations, it's something that we need to be vigilant about in younger populations, as well," Millhuff said. She added that women themselves can play an active role by asking their doctors about cardiovascular risk.

That advice sounds simple. But it rests on a more complicated reality: a healthcare system that has systematically underestimated cardiovascular risk in younger women and is now contending with the consequences.

What this study does not answer

This is a mortality study based on death certificates, not a clinical trial. It can tell us how many women died and from what, but it cannot explain why the rate quadrupled. Possible contributors include rising obesity rates, increased prevalence of metabolic syndrome in younger adults, disparities in healthcare access, and the broader failure to screen. The data cannot disentangle these factors or assign relative weight to each.

The study also cannot determine whether the rise reflects a true increase in disease or improved recognition and documentation of hypertensive heart disease as a cause of death on certificates. Both explanations likely contribute.

Still, the trajectory is clear enough to act on. A fourfold increase over 25 years in any cause of death among young adults warrants attention. That it involves a condition as treatable as high blood pressure makes the trend harder to justify.